Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status.
Jesse Lopes da SilvaLucas Zanetti de AlbuquerqueFabiana Resende RodriguesNina Carrossini BastosIsabele Avila SmallElisa Bouret Campos BarrosoFernando Lopes CorderoDaniel de Souza FernandesEduardo PaulinoAndreia Cristina de MeloPublished in: PloS one (2023)
The strong influence of CDX2 on prognosis requires further investigation. Biological or molecular variability may have impaired the assessment of the impact of the other markers on survival.